Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 5,000 shares at $219.65 ($1.1M) on 2021-06-23, disclosed to the SEC on 2021-06-25.
Open-market sale of $1.1M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-03 | $920K | — | Filing → |